Shelley A. Green

Statistics

Publications

Citations

131

H-Index

Active since

1998

Affiliations

Procter & Gamble (United States)(Current)

Shelley A. Green is an author at Procter & Gamble (United States) specializing in selective cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drug pharmacology, and analgesic pharmacology.

Publications per year

1998–1998

Publications

New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 1. 7-tert-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents: Discovery and Variation of the 5-Keto Substituent

John M. Janusz, Patricia A. Young, James M. Ridgeway et al. · Journal of Medicinal Chemistry · 1998 · 53 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 3. 7-tert-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents: Variations at the 5 Position

John M. Janusz, Patricia A. Young, James M. Ridgeway et al. · Journal of Medicinal Chemistry · 1998 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 2. 7-tert-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents: Variations of the Dihydrobenzofuran Ring

John M. Janusz, Patricia A. Young, Michael W. Scherz et al. · Journal of Medicinal Chemistry · 1998 · 34 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

1–3 of 3